437 related articles for article (PubMed ID: 32071436)
1. Target gene-independent functions of MYC oncoproteins.
Baluapuri A; Wolf E; Eilers M
Nat Rev Mol Cell Biol; 2020 May; 21(5):255-267. PubMed ID: 32071436
[TBL] [Abstract][Full Text] [Related]
2. Myc proteins in cell biology and pathology.
Majello B; Perini G
Biochim Biophys Acta; 2015 May; 1849(5):467-8. PubMed ID: 25534969
[No Abstract] [Full Text] [Related]
3. Transcription-independent functions of MYC: regulation of translation and DNA replication.
Cole MD; Cowling VH
Nat Rev Mol Cell Biol; 2008 Oct; 9(10):810-5. PubMed ID: 18698328
[TBL] [Abstract][Full Text] [Related]
4. Myc and cell cycle control.
Bretones G; Delgado MD; León J
Biochim Biophys Acta; 2015 May; 1849(5):506-16. PubMed ID: 24704206
[TBL] [Abstract][Full Text] [Related]
5. Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas.
Westermann F; Muth D; Benner A; Bauer T; Henrich KO; Oberthuer A; Brors B; Beissbarth T; Vandesompele J; Pattyn F; Hero B; König R; Fischer M; Schwab M
Genome Biol; 2008 Oct; 9(10):R150. PubMed ID: 18851746
[TBL] [Abstract][Full Text] [Related]
6. Drugging MYCN Oncogenic Signaling through the MYCN-PA2G4 Binding Interface.
Koach J; Holien JK; Massudi H; Carter DR; Ciampa OC; Herath M; Lim T; Seneviratne JA; Milazzo G; Murray JE; McCarroll JA; Liu B; Mayoh C; Keenan B; Stevenson BW; Gorman MA; Bell JL; Doughty L; Hüttelmaier S; Oberthuer A; Fischer M; Gifford AJ; Liu T; Zhang X; Zhu S; Gustafson WC; Haber M; Norris MD; Fletcher JI; Perini G; Parker MW; Cheung BB; Marshall GM
Cancer Res; 2019 Nov; 79(21):5652-5667. PubMed ID: 31501192
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of sustained N-myc reduction in rhabdomyosarcomas and transcriptional block by antigene therapy.
Tonelli R; McIntyre A; Camerin C; Walters ZS; Di Leo K; Selfe J; Purgato S; Missiaglia E; Tortori A; Renshaw J; Astolfi A; Taylor KR; Serravalle S; Bishop R; Nanni C; Valentijn LJ; Faccini A; Leuschner I; Formica S; Reis-Filho JS; Ambrosini V; Thway K; Franzoni M; Summersgill B; Marchelli R; Hrelia P; Cantelli-Forti G; Fanti S; Corradini R; Pession A; Shipley J
Clin Cancer Res; 2012 Feb; 18(3):796-807. PubMed ID: 22065083
[TBL] [Abstract][Full Text] [Related]
8. C1orf35 contributes to tumorigenesis by activating c-MYC transcription in multiple myeloma.
Luo SQ; Xiong DH; Li J; Li G; Wang Y; Zhang JM; Bu XF; Hu WX; Hu J
Oncogene; 2020 Apr; 39(16):3354-3366. PubMed ID: 32103167
[TBL] [Abstract][Full Text] [Related]
9. Compensatory RNA polymerase 2 loading determines the efficacy and transcriptional selectivity of JQ1 in Myc-driven tumors.
Donato E; Croci O; Sabò A; Muller H; Morelli MJ; Pelizzola M; Campaner S
Leukemia; 2017 Feb; 31(2):479-490. PubMed ID: 27443262
[TBL] [Abstract][Full Text] [Related]
10. TWIST1 is a direct transcriptional target of MYCN and MYC in neuroblastoma.
Selmi A; de Saint-Jean M; Jallas AC; Garin E; Hogarty MD; Bénard J; Puisieux A; Marabelle A; Valsesia-Wittmann S
Cancer Lett; 2015 Feb; 357(1):412-418. PubMed ID: 25475555
[TBL] [Abstract][Full Text] [Related]
11. Beyond gene expression: how MYC relieves transcription stress.
Papadopoulos D; Uhl L; Ha SA; Eilers M
Trends Cancer; 2023 Oct; 9(10):805-816. PubMed ID: 37422352
[TBL] [Abstract][Full Text] [Related]
12. Menin enhances c-Myc-mediated transcription to promote cancer progression.
Wu G; Yuan M; Shen S; Ma X; Fang J; Zhu L; Sun L; Liu Z; He X; Huang D; Li T; Li C; Wu J; Hu X; Li Z; Song L; Qu K; Zhang H; Gao P
Nat Commun; 2017 May; 8():15278. PubMed ID: 28474697
[TBL] [Abstract][Full Text] [Related]
13. Myc and Ras oncogenes engage different energy metabolism programs and evoke distinct patterns of oxidative and DNA replication stress.
Maya-Mendoza A; Ostrakova J; Kosar M; Hall A; Duskova P; Mistrik M; Merchut-Maya JM; Hodny Z; Bartkova J; Christensen C; Bartek J
Mol Oncol; 2015 Mar; 9(3):601-16. PubMed ID: 25435281
[TBL] [Abstract][Full Text] [Related]
14. The Histone Methyltransferase DOT1L Promotes Neuroblastoma by Regulating Gene Transcription.
Wong M; Tee AEL; Milazzo G; Bell JL; Poulos RC; Atmadibrata B; Sun Y; Jing D; Ho N; Ling D; Liu PY; Zhang XD; Hüttelmaier S; Wong JWH; Wang J; Polly P; Perini G; Scarlett CJ; Liu T
Cancer Res; 2017 May; 77(9):2522-2533. PubMed ID: 28209620
[TBL] [Abstract][Full Text] [Related]
15. Identification of target genes of oncogenic transcription factors.
Boyd KE; Farnham PJ
Proc Soc Exp Biol Med; 1999 Oct; 222(1):9-28. PubMed ID: 10510243
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D
J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166
[TBL] [Abstract][Full Text] [Related]
17. The MYCN oncoprotein as a drug development target.
Lu X; Pearson A; Lunec J
Cancer Lett; 2003 Jul; 197(1-2):125-30. PubMed ID: 12880971
[TBL] [Abstract][Full Text] [Related]
18. Non-transcriptional control of DNA replication by c-Myc.
Dominguez-Sola D; Ying CY; Grandori C; Ruggiero L; Chen B; Li M; Galloway DA; Gu W; Gautier J; Dalla-Favera R
Nature; 2007 Jul; 448(7152):445-51. PubMed ID: 17597761
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in searching c-Myc transcriptional cofactors during tumorigenesis.
Caforio M; Sorino C; Iacovelli S; Fanciulli M; Locatelli F; Folgiero V
J Exp Clin Cancer Res; 2018 Sep; 37(1):239. PubMed ID: 30261904
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA EMS connects c-Myc to cell cycle control and tumorigenesis.
Wang C; Yang Y; Zhang G; Li J; Wu X; Ma X; Shan G; Mei Y
Proc Natl Acad Sci U S A; 2019 Jul; 116(29):14620-14629. PubMed ID: 31262817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
